These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10544253)

  • 1. 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells).
    Miura D; Manabe K; Gao Q; Norman AW; Ishizuka S
    FEBS Lett; 1999 Oct; 460(2):297-302. PubMed ID: 10544253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
    Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
    J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (23S)- and (23R)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1alpha,25-dihydroxyvitamin D(3).
    Ishizuka S; Miura D; Ozono K; Saito M; Eguchi H; Chokki M; Norman AW
    Steroids; 2001; 66(3-5):227-37. PubMed ID: 11179730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D(3)-26, 23-lactone analogs on 25-hydroxyvitamin-D(3)-24-hydroxylase gene expression induced by 1alpha,25-dihydroxy-vitamin D(3) in human promyelocytic leukemia (HL-60) cells.
    Ishizuka S; Miura D; Eguchi H; Ozono K; Chokki M; Kamimura T; Norman AW
    Arch Biochem Biophys; 2000 Aug; 380(1):92-102. PubMed ID: 10900137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic Actions in Vivo of (23S)-25-Dehydro-1alpha-Hydroxyvitamin D(3-)26,23-Lactone on Calcium Metabolism Induced by 1alpha,25-Dihydroxyvitamin D(3).
    Ishizuka S; Miura D; Ozono K; Chokki M; Mimura H; Norman AW
    Endocrinology; 2001 Jan; 142(1):59-67. PubMed ID: 11145567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
    Ishizuka S; Kurihara N; Hiruma Y; Miura D; Namekawa J; Tamura A; Kato-Nakamura Y; Nakano Y; Takenouchi K; Hashimoto Y; Nagasawa K; Roodman GD
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):269-77. PubMed ID: 18501591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
    Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
    Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor.
    Ochiai E; Miura D; Eguchi H; Ohara S; Takenouchi K; Azuma Y; Kamimura T; Norman AW; Ishizuka S
    Mol Endocrinol; 2005 May; 19(5):1147-57. PubMed ID: 15650022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
    Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
    J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
    Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study.
    Song X; Bishop JE; Okamura WH; Norman AW
    Endocrinology; 1998 Feb; 139(2):457-65. PubMed ID: 9449611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function.
    Ozono K; Saito M; Miura D; Michigami T; Nakajima S; Ishizuka S
    J Biol Chem; 1999 Nov; 274(45):32376-81. PubMed ID: 10542279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells.
    Rao DS; Campbell MJ; Koeffler HP; Ishizuka S; Uskokovic MR; Spagnuolo P; Reddy GS
    Steroids; 2001; 66(3-5):423-31. PubMed ID: 11179751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of TEI-9647 derivatives as Vitamin D3 antagonists.
    Takenouchi K; Sogawa R; Manabe K; Saitoh H; Gao Q; Miura D; Ishizuka S
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):31-4. PubMed ID: 15225742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis.
    Nakagawa K; Sowa Y; Kurobe M; Ozono K; Siu-Caldera ML; Reddy GS; Uskokovic MR; Okano T
    Steroids; 2001; 66(3-5):327-37. PubMed ID: 11179741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
    Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
    Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.
    Berry DM; Meckling-Gill KA
    Endocrinology; 1999 Oct; 140(10):4779-88. PubMed ID: 10499538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-specific control of differentiation and apoptosis of human promyelocytic leukemia (HL-60) cells by A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and its 20-epimer.
    Nakagawa K; Kurobe M; Konno K; Fujishima T; Takayama H; Okano T
    Biochem Pharmacol; 2000 Dec; 60(12):1937-47. PubMed ID: 11108811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.